FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to nicotinic acetylcholine receptor blocking biologically active peptides which can find application in biochemistry, biotechnology and medicine. The peptide azemyopsin has an amino acid sequence: H2N-Asp1-Asn2-Trp3-Trp4-Pro5-Lys6-Pro7-Pro8-His9-Gln10-Gly11 Pro12-Arg13-Pro14-Pro15-Arg16-Pro17-Arg18-Pro19-Lys20-Pro21-COX wherein X is a group OH or NH2, and has an ability to react selectively with nicotine muscarinic receptors. The peptide may be used an a base for preparing myorelaxants selectively blocking muscarinic receptors.
EFFECT: invention presents a new type of natural toxins reacting with nicotine receptors and containing no disulphide bonds.
2 cl, 5 dwg, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE HAVING HIGH AFFINITY TO TYPE ALPHA7 HUMAN NICOTINIC RECEPTOR AND USE THEREOF | 2011 |
|
RU2455359C1 |
ALPHA-CONOTOXIN PnIA ANALOGUE SHOWING HIGH AFFINITY AND SELECTIVITY TO ACETYLCHOLINE-BINDING PROTEIN FROM APLYSIA CALIFORNICA | 2011 |
|
RU2458068C1 |
PEPTIDES AND THEIR DERIVATIVES WHICH INTERACT WITH NICOTINIC ACETYLCHOLINE RECEPTOR AND SUITABLE FOR USE IN COSMETOLOGY AGAINST MIMIC AND AGE-RELATED WRINKLES | 2013 |
|
RU2524428C1 |
ANALOGUE OF ALPHA-CONOTOXIN RGIA FOR TREATING PAIN | 2016 |
|
RU2731217C2 |
NEW OCTAPEPTIDE COMPOUNDS AND THEIR THERAPEUTIC APPLICATION | 2011 |
|
RU2595525C2 |
NEW OCTAPEPTIDE COMPOUNDS REPRESENTING SOMATOSTATIN DERIVATIVES | 2009 |
|
RU2547940C2 |
SYNTHETIC ANTIGEN HAVING ABILITY TO FIX AUTOANTIBODIES TO MUSCARINE M2-RECEPTOR | 2012 |
|
RU2502743C1 |
PEPTIDES INHIBITING NEURON EXOCYTOSIS | 2007 |
|
RU2461568C2 |
PEPTIDE ANALOGUES GH-RH WITH OPPOSING ACTION, WAY OF DEPRESSION OF GH LEVEL, WAY OF DEPRESSION OF IGF-INIGF-II LEVEL, APPLICATION FOR INHIBITION OF GROWTH OF CANCER CELLS, PHARMACOLOGICALLY ACCEPTABLE COMPOSITION (VARIANTS) | 2004 |
|
RU2335506C2 |
PEPTIDE HAVING ACTIVITY OF HUMAN SLURP-1 PROTEIN AND ITS APPLICATION FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA, PHARMACEUTICAL COMPOSITION FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA, AND METHOD FOR SUPPRESSION OF GROWTH OF CARCINOMA AND GLIOMA USING THE SPECIFIED PEPTIDE | 2022 |
|
RU2792364C1 |
Authors
Dates
2013-01-27—Published
2011-10-26—Filed